235 related articles for article (PubMed ID: 24859392)
41. Clinical Profile and Prevalence of H Pylori, Iga-Ttg, and Spectrum of Duodenal Abnormalities in Non Ulcer Dyspepsia.
Mamidi S; Bansal N; Singhal A; Singh PK; Sharma PK
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443497
[TBL] [Abstract][Full Text] [Related]
42. Lack of Utility of Anti-tTG IgG to Diagnose Celiac Disease When Anti-tTG IgA Is Negative.
Absah I; Rishi AR; Gebrail R; Snyder MR; Murray JA
J Pediatr Gastroenterol Nutr; 2017 May; 64(5):726-729. PubMed ID: 28437323
[TBL] [Abstract][Full Text] [Related]
43. [Usefulness of anti-transglutaminase antibodies in the diagnosis of celiac disease].
Fernández ML; Vivas S; Ruiz de Morales JM; Marugán JM
Gastroenterol Hepatol; 2005 Oct; 28(8):437-40. PubMed ID: 16185576
[TBL] [Abstract][Full Text] [Related]
44. Strongly positive tissue transglutaminase antibodies are associated with Marsh 3 histopathology in adult and pediatric celiac disease.
Donaldson MR; Book LS; Leiferman KM; Zone JJ; Neuhausen SL
J Clin Gastroenterol; 2008 Mar; 42(3):256-60. PubMed ID: 18223500
[TBL] [Abstract][Full Text] [Related]
45. Screening of the adult population in Iran for coeliac disease: comparison of the tissue-transglutaminase antibody and anti-endomysial antibody tests.
Akbari MR; Mohammadkhani A; Fakheri H; Javad Zahedi M; Shahbazkhani B; Nouraie M; Sotoudeh M; Shakeri R; Malekzadeh R
Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1181-6. PubMed ID: 17033439
[TBL] [Abstract][Full Text] [Related]
46. IgA antibodies to tissue transglutaminase: An effective diagnostic test for celiac disease.
Troncone R; Maurano F; Rossi M; Micillo M; Greco L; Auricchio R; Salerno G; Salvatore F; Sacchetti L
J Pediatr; 1999 Feb; 134(2):166-71. PubMed ID: 9931524
[TBL] [Abstract][Full Text] [Related]
47. Immunohistologic analysis of the duodenal bulb: a new method for celiac disease diagnosis in children.
De Leo L; Villanacci V; Ziberna F; Vatta S; Martelossi S; Di Leo G; Zanchi C; Bramuzzo M; Giudici F; Ventura A; Not T
Gastrointest Endosc; 2018 Sep; 88(3):521-526. PubMed ID: 29807020
[TBL] [Abstract][Full Text] [Related]
48. Clinical and Immunologic Features of Ultra-Short Celiac Disease.
Mooney PD; Kurien M; Evans KE; Rosario E; Cross SS; Vergani P; Hadjivassiliou M; Murray JA; Sanders DS
Gastroenterology; 2016 May; 150(5):1125-1134. PubMed ID: 26836585
[TBL] [Abstract][Full Text] [Related]
49. Serum positivity of serum anti-tissue transglutaminase immunoglobulin A antibodies in Japanese children with inflammatory bowel disease.
Kurasawa S; Sado T; Kato S; Iwaya M; Nakayama Y
Pediatr Int; 2023 Jan; 65(1):e15485. PubMed ID: 36702637
[TBL] [Abstract][Full Text] [Related]
50. Prevalence of celiac disease in first-degree relative of children in Sistan and Baluchestan province (Iran).
Shahraki T; Hill I
J Dig Dis; 2016 Oct; 17(10):685-691. PubMed ID: 27561031
[TBL] [Abstract][Full Text] [Related]
51. Is immunoglobulin A anti-tissue transglutaminase antibody a reliable serological marker of coeliac disease?
Lock RJ; Stevens S; Pitcher MC; Unsworth DJ
Eur J Gastroenterol Hepatol; 2004 May; 16(5):467-70. PubMed ID: 15097038
[TBL] [Abstract][Full Text] [Related]
52. Influence of age and genetic risk on anti-tissue transglutaminase IgA titers.
Vécsei A; Arenz T; Heilig G; Arenz S; Bufler P; Koletzko S
J Pediatr Gastroenterol Nutr; 2009 May; 48(5):544-9. PubMed ID: 19367177
[TBL] [Abstract][Full Text] [Related]
53. Clinical presentation of celiac disease and the diagnostic accuracy of serologic markers in children.
Lurz E; Scheidegger U; Spalinger J; Schöni M; Schibli S
Eur J Pediatr; 2009 Jul; 168(7):839-45. PubMed ID: 18923841
[TBL] [Abstract][Full Text] [Related]
54. Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease.
Tursi A; Brandimarte G; Giorgetti GM
J Clin Gastroenterol; 2003 Mar; 36(3):219-21. PubMed ID: 12590232
[TBL] [Abstract][Full Text] [Related]
55. Increased density of tolerogenic dendritic cells in the small bowel mucosa of celiac patients.
Vorobjova T; Uibo O; Heilman K; Uibo R
World J Gastroenterol; 2015 Jan; 21(2):439-52. PubMed ID: 25593459
[TBL] [Abstract][Full Text] [Related]
56. What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis.
Hopper AD; Hadjivassiliou M; Hurlstone DP; Lobo AJ; McAlindon ME; Egner W; Wild G; Sanders DS
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):314-20. PubMed ID: 18328437
[TBL] [Abstract][Full Text] [Related]
57. Prevalence and characteristics of celiac disease in South African patients with type 1 diabetes mellitus: Results from the Durban Diabetes and Celiac Disease Study.
Paruk IM; Naidoo VG; Pirie FJ; Maharaj S; Nkwanyana NM; Dinnematin HL; Ganie Y; Ramdial PK; Motala AA
J Gastroenterol Hepatol; 2019 Apr; 34(4):673-678. PubMed ID: 30600564
[TBL] [Abstract][Full Text] [Related]
58. The prevalence of coeliac disease in patients fulfilling Rome III criteria for irritable bowel syndrome.
Shalaby SA; Sayed MM; Ibrahim WA; Abdelhakam SM; Rushdy M
Arab J Gastroenterol; 2016 Jun; 17(2):73-7. PubMed ID: 27349575
[TBL] [Abstract][Full Text] [Related]
59. Comparison of IgA endomysium antibody and IgA tissue transglutaminase antibody in celiac disease.
Gillett HR; Freeman HJ
Can J Gastroenterol; 2000 Sep; 14(8):668-71. PubMed ID: 11185530
[TBL] [Abstract][Full Text] [Related]
60. Autoantibodies to tissue transglutaminase as predictors of celiac disease.
Dieterich W; Laag E; Schöpper H; Volta U; Ferguson A; Gillett H; Riecken EO; Schuppan D
Gastroenterology; 1998 Dec; 115(6):1317-21. PubMed ID: 9834256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
